A STUDY TO EVALUATE EFFICACY AND SAFETY OF PEGINTERFERON ALFA-2A (PEGASYS) AND ADEFORVIR DIPIVOXIL (ADV) IN PARTICIPANTS WITH LAMIVUDINE-RESISTANT HEPATITIS B E ANTIGEN (HBEAG)-POSITIVE CHRONIC HEPATITIS B: